People are being encouraged to be vigilant for the signs of a 'silent killer' cancer, known to be one of the most difficult ...

According to the American Lung Association, the national five-year lung cancer survival rate is about 29.7 percent. The ...

When he started having symptoms, “cancer was the farthest thing from my mind,” he says. How a liver transplant and his dog ...

Amini: From a radiation standpoint, this has changed the landscape of our field. A large proportion of my practice is stage IV disease, where patients who are on these excellent systemic therapies are ...

Company Served as Sponsor and Provided Operational Leadership for Study Conducted in Partnership with TGen and Virta ...

Last month, the United States Food and Drug Administration (FDA) approved a new wearable device for treating pancreatic cancer. This device, called Optune | Cancer ...

Significantly more patients had no chemotherapy-induced thrombocytopenia-induced modification of chemo dose with romiplostim vs placebo.

Immuneering will present an analysis of circulating tumor DNA (ctDNA) from ≥64 patients with RAS-mutant solid tumors treated with atebimetinib, showing that acquired MAPK pathway alterations are ...

Extended long-term survival observed after an additional year of follow-up in ongoing phase 2a clinical trial, with 50% of 46 patients with advanced non-small cell lung cancer (NSCLC) treated with ...

Antibiotic use is associated with worse outcomes in patients with gastrointestinal (GI) and liver cancer who were receiving ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...